Trial Profile

A clinical trial evaluating KB-3061

Status: Active, no longer recruiting

Phase of Trial: Phase II

Latest Information Update: 05 Dec 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs BHV-7000 (Primary)
Indications Bipolar disorders; Epilepsy; Infantile spasms; Mood disorders; Pain
Focus Biomarker; Pharmacodynamics
Acronyms EEG

Most Recent Events

01 Dec 2023 Results presented in the Biohaven Pharmaceuticals Media Release.
14 Nov 2023 According to a Pharmaceutical Holding Company Media Release, the Company expects to share additional results from this EEG study at the upcoming American Epilepsy Society (AES) medical meeting in December.
05 Sep 2023 According to a Pharmaceutical Holding Company Media Release, company expects to present the additional details and analyses from this EEG study at upcoming scientific meetings.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com